(Q47315222)

English

Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators.

scientific article published in February 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9036746

Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators. (English)

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9036746

1 reference

based on heuristic

inferred from title

revascularization

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

16

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9036746

A Michael Lincoff

1

object named as

A M Lincoff

1 reference

Europe PubMed Central

13 January 2018

3

object named as

R M Califf

1 reference

Europe PubMed Central

13 January 2018

author name string

J E Tcheng

2

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9036746

T Bass

4

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9036746

J J Popma

5

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9036746

P S Teirstein

6

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9036746

N S Kleiman

7

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9036746

L J Hattel

8

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9036746

H V Anderson

9

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9036746

J J Ferguson

10

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9036746

C F Cabot

11

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9036746

K M Anderson

12

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9036746

L G Berdan

13

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9036746

M H Musco

14

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9036746

H F Weisman

15

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9036746

language of work or name

0 references

publication date

1 February 1997

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9036746

American Journal of Cardiology

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9036746

79

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9036746

286-291

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9036746

3

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9036746

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900749-7

7 January 2021

Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900749-7

7 January 2021

Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900749-7

7 January 2021

Platelets and vascular thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900749-7

7 January 2021

Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900749-7

7 January 2021

Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention. EPIC Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900749-7

7 January 2021

Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900749-7

7 January 2021

Peripheral vascular complications of coronary angioplasty by the femoral and brachial techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900749-7

7 January 2021

Subcutaneous heparin in postangioplasty management: comparative trial with intravenous heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900749-7

7 January 2021

Randomized prospective evaluation of prolonged versus abbreviated intravenous heparin therapy after coronary angioplasty.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900749-7

7 January 2021

Activated clotting times and activated partial thromboplastin times in patients undergoing coronary angioplasty who receive bolus doses of heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900749-7

7 January 2021

The relationship of anticoagulation level and complications after successful percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900749-7

7 January 2021

Identifiers

10.1016/S0002-9149(96)00749-7

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9036746

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9036746

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47315222&oldid=1694331739"